We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

152 hedge funds and large institutions have $1.26B invested in Acorda Therapeutics in 2017 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 61 increasing their positions, 40 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 40

26% more capital invested

Capital invested by funds: $1B → $1.26B (+$258M)

6% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 17

1% more funds holding

Funds holding: 151 → 152 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

19% less call options, than puts

Call options by funds: $6.72M | Put options by funds: $8.28M

Holders
152
Holders Change
+1
Holders Change %
+0.66%
% of All Funds
3.79%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
18
Increased
61
Reduced
40
Closed
17
Calls
$6.72M
Puts
$8.28M
Net Calls
-$1.56M
Net Calls Change
+$10.6M

Top Buyers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
+$32.1M
2
SCM
Scopia Capital Management
New York
+$27.5M
3
Invesco
Invesco
Georgia
+$15.4M
4
BBA
Baker Bros. Advisors
New York
+$11.4M
5
Deutsche Bank
Deutsche Bank
Germany
+$9.45M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$20.3M
2
CI
Cambiar Investors
Colorado
-$11.8M
3
GTC
Ghost Tree Capital
New York
-$7.88M
4
State Street
State Street
Massachusetts
-$6.39M
5
USAA
United Services Automobile Association
Texas
-$4.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
US Bancorp
151
US Bancorp
Minnesota
$4K – – –
IWM
152
IHT Wealth Management
Illinois
$2K – – –
Envestnet Asset Management
153
Envestnet Asset Management
Illinois
$1K – – –
PFBT
154
Parkside Financial Bank & Trust
Missouri
$1K – – –
TWA
155
TCI Wealth Advisors
Arizona
$1K – – –
GTC
156
Ghost Tree Capital
New York
– -$7.88M -3,333 Closed
Millennium Management
157
Millennium Management
New York
– -$3.92M -1,660 Closed
CS
158
Candriam SCA
Luxembourg
– -$1.4M -592 Closed
TC
159
TFS Capital
Pennsylvania
– -$897K -379 Closed
BPM
160
Bowling Portfolio Management
Ohio
– -$807K -341 Closed
HP
161
Hikari Power
Japan
– -$703K -297 Closed
Connor, Clark & Lunn Investment Management (CC&L)
162
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$660K -279 Closed
PA
163
Perceptive Advisors
New York
– -$626K -265 Closed
Ohio Public Employees Retirement System (OPERS)
164
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$559K -236 Closed
Skandinaviska Enskilda Banken (SEB)
165
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$426K -180 Closed
SCA
166
Secor Capital Advisors
New York
– -$417K -176 Closed
HIMCH
167
Hartford Investment Management Co (HIMCO)
Connecticut
– -$242K -103 Closed
LCM
168
Laurion Capital Management
New York
– -$219K -93 Closed
PAM
169
Paradigm Asset Management
New York
– -$43.3K -18 Closed
Walleye Trading
170
Walleye Trading
New York
– -$10 -4 Closed
KF
171
Krilogy Financial
Missouri
– -$4K -2 Closed
Creative Planning
172
Creative Planning
Kansas
– -$2K -1 Closed
AIM
173
Acrospire Investment Management
Illinois
– -$1K – –
3 4 5 6
7

ACOR Hedge Fund Activity: Q3 2017 in Review

152 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q3 2017, worth a combined $1.26B — up 26% from $1B a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new ACOR positions and 17 closed out — a net gain of 1 holder — while 61 added to existing stakes and 40 trimmed.

The largest buyer was PFM Health Sciences, adding an estimated $32.1M. The largest seller was Citadel Advisors, cutting an estimated $20.3M.

  • 152 institutional investors held Acorda Therapeutics (ACOR) as of Q3 2017, up from 151 in Q2 2017.
  • Funds reported $1.26B of Acorda Therapeutics stock for Q3 2017, up 26% quarter-over-quarter.
  • 18 funds opened new Acorda Therapeutics positions in Q3 2017 and 17 closed out, a net change of +1 holder.
  • The largest Acorda Therapeutics buyer in Q3 2017 was PFM Health Sciences, an estimated $32.1M added.
  • The largest Acorda Therapeutics seller in Q3 2017 was Citadel Advisors, an estimated $20.3M sold.

Based on aggregated 13F filings for Q3 2017.